Guide for Authors
Official Journal of the
International Association for Pharmaceutical Technology
The
European Journal of Pharmaceutics and Biopharmaceutics provides a medium for publication
of novel and innovative research from areas of pharmaceutical technology, drug delivery systems, controlled release systems, drug targeting,
physical pharmacy, biopharmaceutics, drug development, drug and prodrug design, pharmaceutical analysis, drug stability, quality control,
GMP, regulatory aspects, pharmaceutical packaging, and phytochemistry.
The pharmaceutical biotechnology section provides a forum
for the publication of papers on scientific, developmental, regulatory and manufacturing issues concerning the development of biopharmaceuticals,
uniquely combining expert contributions and opinions of authors from the fields of pharmaceutics and biotechnology. This scope encompasses
modern biopharmaceuticals (e.g., proteins and nucleic acids), biosimilars/biogenerics as well as 'traditional' products such as antibiotics.
"THE RULES OF 3"
The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following
three criteria before they submit a manuscript and set the whole process of editing and reviewing at work. The rules are also used as
guidelines for the peer review of manuscripts.
CLICK HERE
to view the "Rules of 3".
Types of paper
The following types
of papers are considered by the Editors: Research Papers, Review Articles, and Notes.
Ethics in Publishing
For information on Ethics
in Publishing and Ethical guidelines for journal publication see
http://www.elsevier.com/publishingethics and
http://www.elsevier.com/ethicalguidelines.
Policy and ethics
The work described in your article must have been carried out in accordance
with
The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans http://www.wma.net/e/policy/b3.htm;
EC Directive 86/609/EEC for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm;
Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. This must be stated
at an appropriate point in the article.
Conflict of interest
All authors
are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with
other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived
to influence, their work. See also
http://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission of an article implies that the work described has not been published previously (except
in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication
elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was
carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without
the written consent of the copyright-holder.
Copyright
Upon acceptance
of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright see
http://www.elsevier.com/copyright).
Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding
author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this
agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation
within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other
derivative works, including compilations and translations (please consult
http://www.elsevier.com/permissions). If excerpts
from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s)
in the article. Elsevier has preprinted forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details
you are referred to:
http://www.elsevier.com/authorsrights.
Role of the
funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation
of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation
of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such
involvement then this should be stated. Please see
http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose
articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions
of their grant awards. To learn more about existing agreements and policies please visit
http://www.elsevier.com/fundingbodies.
Language and language services
Please write your text in good English (American or British usage is accepted,
but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission
please visit
http://www.elsevier.com/languagepolishing or our customer support site at
http://epsupport.elsevier.com
for more information. Please note Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside
vendors through our services or in any advertising. For more information please refer to our Terms & Conditions:
http://www.elsevier.com/termsandconditions.
Submission
Submission to this journal proceeds totally online and you will be guided stepwise through
the creation and uploading of your files. The system automatically converts source files to a single PDF file of the article, which is
used in the peer-review process. Please note that even though manuscript source files are converted to PDF files at submission for the
review process, these source files are needed for further processing after acceptance. All correspondence, including notification of
the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.
Additional information
US National Institutes of Health (NIH) voluntary posting ("Public Access")
policy.
Elsevier facilitates author posting in connection with the voluntary posting request of the NIH (referred to as
the NIH "Public Access Policy"; see
http://publicaccess.nih.gov/) by posting the peer-reviewed author's manuscript directly
to PubMed Central on request from the author, after formal publication. Upon notification from Elsevier of acceptance, we will ask you
to confirm via e-mail (by e-mailing us at
NIHauthorrequest@elsevier.com) that your work has received NIH funding (with
the NIH award number, as well as the name and e-mail address of the Prime Investigator) and that you intend to respond to the NIH request.
Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review
comments, for posting 12 months after the formal publication date. This will ensure that you will have responded fully to the NIH request
policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is prohibited. Individual
modifications to this general policy may apply to some Elsevier journals and its society publishing partners.
Use of wordprocessing software
It
is important that the file be saved in the native format of the wordprocessor used. The text should be in single-column format. Keep
the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular,
do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts
etc. Do not embed "graphically designed" equations or tables, but prepare these using the wordprocessor's facility. When preparing tables,
if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs,
not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also
the Guide to Publishing with Elsevier:
http://www.elsevier.com/guidepublication). Do not import the figures into the text
file but, instead, indicate their approximate locations directly in the electronic text and on the manuscript. See also the section on
Electronic illustrations.
To avoid unnecessary errors you are strongly advised to use the "spell-check" and "grammar-check" functions
of your wordprocessor.
LaTeX
If the LaTeX file is suitable, proofs will
be produced without rekeying the text. The article should preferably be written using Elsevier's document class "elsarticle", or alternatively
the standard document class "article".
The Elsevier LaTeX style file package (including detailed instructions for LaTeX preparation)
can be obtained from the Quickguide:
http://www.elsevier.com/latex. It consists of the file: elsarticle.cls, complete user
documentation for the class file, bibliographic style files in various styles, and template files for a quick start.
RESEARCH PAPERS
Should contain the following sections: Introduction, Theoretical Development
(if applicable), Materials and Methods, Results, Discussion (or Results and Discussion) and References. For purely theoretical papers,
appropriate sections may be selected.
It should define the purpose of
the research and reveal its connections with the principal work of other authors in the field.
Materials and methods
It should include materials, standard techniques and procedures relevant to the study. Published
procedures and techniques should be cited unless significant modifications are involved. Exact specification of relevant materials and
equipment must be given. Chemical terms must conform with IUPAC rules. Trademarks of commercial products must be labelled using a superscripted
'(r)'. Names of products and equipment mentioned in the Materials and Methods section must be accompanied by the name of the manufacturer
or distributor, location and state or country. This information must be stated in parentheses in the text, and not as a footnote. Any
potential hazards connected with materials and procedures must be mentioned. A precise and detailed description should be given of those
steps which are of vital importance in carrying out any repetition of the work. The Declarations of Helsinki and Tokyo for humans, and
the European Community guidelines as accepted principles for the use of experimental animals, must be adhered to. Therefore,
EJPB
will only consider manuscripts that describe experiments that have been carried out under approval of an institutional or local ethics
committee.
Authors must state in the manuscript that the protocol complies with the particular recommendation and that approval of
their protocols was obtained.
Equations must be part of the text and consecutively numbered on the right hand side
using numbers in parentheses. References to equations in the text are also to be made with parentheses, e.g. using Eq. (3), etc.
Organic formulas, both in figures and in the text, should be numbered in boldface arabic numerals.
SI units
must be used throughout.
Theory/calculation
A Theory section should
extend, not repeat, the background to the article already dealt with in the Introduction and lay the foundation for further work. In
contrast, a Calculation section represents a practical development from a theoretical basis.
Results
Results may be presented in tables, figures or schemes which must be referred to in the accompanying text, using
appropriate numbering, e.g. Fig. 1, Table 2.
Discussion
It should focus
on the interpretation of the results. It might be appropriate to combine RESULTS AND DISCUSSION in one section. If necessary at all,
use CONCLUSIONS only to illustrate the general implication of the results and do not summarize the previous text.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which
may stand alone or form a subsection of a Discussion or Results and Discussion section.
Appendices
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in
appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on.
Essential title page information
•
Title.
Concise and informative. Titles are often
used in information-retrieval systems. Avoid abbreviations and formulae where possible.
•
Author names and affiliations.
Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses
(where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the
author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name,
and, if available, the e-mail address of each author.
•
Corresponding author.
Clearly indicate who will handle
correspondence at all stages of refereeing and publication, also post-publication.
Ensure that telephone and fax numbers (with country
and area code) are provided in addition to the e-mail address and the complete postal address.
•
Present/permanent
address.
If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address"
(or "Permanent address") may be indicated as a footnote to that author's name. The address at which the author actually did the work
must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
It should contain a brief and clear description of the aim of the paper, its principal results and major conclusions
(100--200 words). The abstract should include all keywords pertinent to the subject.
Keywords
Indicate 5 to 10 English keywords. They should be carefully selected in order to improve accessibility of scientific
information in the manuscript. Keywords commonly used in international abstracting services will be preferred.
Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the
first page of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well
as in the footnote. Ensure consistency of abbreviations throughout the article.
Acknowledgements
Acknowledgements of financial support, gifts, technical help or other assistance may be given in an unnumbered paragraph under
this heading preceding the references.
Math formulae
Present simple formulae
in the line of normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y.
In principle, variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Number consecutively
any equations that have to be displayed separately from the text (if referred to explicitly in the text).
Footnotes
Footnotes should be used sparingly. Number them consecutively throughout the article, using superscript
Arabic numbers. Many wordprocessors build footnotes into the text, and this feature may be used. Should this not be the case, indicate
the position of footnotes in the text and present the footnotes themselves separately at the end of the article. Do not include footnotes
in the Reference list.
Table footnotes
Indicate each footnote in a table with a superscript lowercase letter.
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics"
or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number
the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
•
Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
• Submit
each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless
of the application used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats
(note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings.
Embed the font or save the text as "graphics".
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a
minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications
please supply "as is".
Please do not:
• Supply embedded graphics in your wordprocessor (spreadsheet, presentation)
document;
• Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
•
Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Figures
Figures must be presented on separate sheets in consecutive order using Arabic numerals. Each figure
should be provided with an instructive title and explanatory information. The legend should be typed separately from the figures. To
ensure identification of the figures, indicate figure number and name of author using soft pencil. Submit original drawings in black
ink on good quality white paper. High-contrast photographs are equally acceptable. One original set is required with the submission.
Numbering and lettering of figures should be carefully accepted in order to ensure readability after photographic reduction of the figure.
Use only standard symbols to mark datapoints. Explanation of curves and symbols should be in the legend rather than part of the drawing,
unless this is detrimental to clarity. Indicate SI units of measure in parentheses.
Colour illustrations should be submitted
as original photographs, high-quality computer prints or transparancies, close to the size expected in publication or as 35 mm slides.
Polaroid colour prints are
not suitable. If, together with your accepted article, you submit usable colour figures then Elsevier
will ensure , at no additional charge, that these figures will appear in colour on the web (e.g., ScienceDirect and other sites) regardless
of whether or not these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive
information regarding the total cost from Elsevier after receipt of your accepted article. For more detailed instructions please visit
our artwork instruction pages at
http://www.elsevier.com/artworkinstructions.
Please note: Because of
technical complications which can arise by converting colour figures to 'grey scale' (for the printed version should you not opt for
colour in print) please submit in addition usable black and white prints corresponding to all the colour illustrations.
A limited
number of colour photographs are accepted free of charge with prior permission from the Editor-in-Chief. Colour photographs above this
number will only be reproduced at the expense of the author(s). The 2006 price for colour figures is 285 Euro for the first page and
191 Euro for subsequent pages.
Figure captions
Ensure that each
illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (
not
on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols
and abbreviations used.
Tables
Tables must be presented on separate sheets
in consecutive order using Arabic numerals. The table headings must include a descriptive title and additional information to make the
table self-explanatory. Some information may be given by using lower-case letter designations referring to footnotes at the bottom of
the table. Indicate SI units of measure in parentheses.
References
References
must be arranged as follows:
[1] A.-L. Cornaz, P. Buri, Nasal mucosa as an absorption barrier, Eur. J. Pharm. Biopharm. 40 (1994)
261--270.
[5] C. Lanczos, Applied Analysis, Prentice-Hall, Englewood Cliffs, NJ, 1967, pp. 272--280.
[10] D.M. Barends,
Stability of active ingredients, in: H. Muller, W.H. Oeser (Eds.), Drug Master Files, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart,
Germany, 1992, pp. 121--128.
[14] E.A. Balazs, Ultrapure hyaluronic acid and the use thereof, U.S. Patent 4,141,973 (1979).
The system used by Chemical Abstracts (Chemical Abstracts Service Source Index) must be followed for the abbreviations of journals.
Reference (4) is for patents, including the status, international country code, number of patent and year.
Articles in Special
Issues: Please ensure that the words 'this issue' are added (in the list and text) to any references to other articles in this Special
Issue.
Citation in text
Please ensure that every reference cited
in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished
results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references
are included in the reference list they should follow the standard reference style of the journal and should include a substitution of
the publication date with either "Unpublished results" or "Personal communication" Citation of a reference as "in press" implies that
the item has been accepted for publication.
Web references
As a minimum,
the full URL should be given. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.),
should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired,
or can be included in the reference list.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in the text) to other articles
in the same Special Issue.
Reference style
Text: Indicate
references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s)
must always be given.
Example: "..... as demonstrated [3,6]. Barnaby and Jones [8] obtained a different result ...."
List:
Number the references (numbers in square brackets) in the list in the order in which they appear in the text.
Examples:
Reference to a journal publication:
[1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton, The art of writing a scientific article,
J. Sci. Commun. 163 (2000) 51-59.
Reference to a book:
[2] W. Strunk Jr., E.B. White, The Elements of Style, third ed., Macmillan,
New York, 1979.
Reference to a chapter in an edited book:
[3] G.R. Mettam, L.B. Adams, How to prepare an electronic version of
your article, in: B.S. Jones, R.Z. Smith (Eds.), Introduction to the Electronic Age, E-Publishing Inc., New York, 1999, pp. 281-304.
Journal abbreviations source
Journal names should be abbreviated according to
Index Medicus journal
abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html;
List of serial title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service):
http://www.cas.org/sent.html.
Supplementary
material
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary
files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images,
background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of
your article in Elsevier Web products, including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your
submitted material is directly usable, please ensure that data are provided in one of our recommended file formats. Authors should submit
the material in electronic format together with the article and supply a concise and descriptive caption for each file. Video files:
please supply 'stills' with your files: you can choose any frame from the video or make a separate image. These will be used instead
of standard icons and will personalize the link to your supplementary information. For more detailed instructions please visit our artwork
instruction pages at
http://www.elsevier.com/artworkinstructions.
Submission
checklist
It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's
Editor for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are
present:
One Author designated as corresponding Author:
• E-mail address
• Full postal address
• Telephone
and fax numbers
All necessary files have been uploaded
• Keywords
• All figure captions
• All tables (including
title, description, footnotes)
Further considerations
• Manuscript has been "spellchecked" and "grammar-checked"
•
References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text,
and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
•
Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced
in color on the Web (free of charge) and in black-and-white in print
• If only color on the Web is required, black and white
versions of the figures are also supplied for printing purposes
For any further information please visit our customer support site
at
http://epsupport.elsevier.com.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to
electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon
the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly
'Articles in press' because they have not yet received their full bibliographic information. The correct format for citing a DOI is shown
as follows (example taken from a document in the journal
Physics Letters B):
doi:10.1016/j.physletb.2003.10.071
When
you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download
the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe
Reader version 7 (or higher) available free from
http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how
to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site:
http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and
return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then
mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan
the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the
text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission
from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure
that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent
corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of
your article if no response is received.
Offprints
The corresponding author,
at no cost, will be provided with a PDF file of the article via e-mail. The PDF file is a watermarked version of the published article
and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.
Additional information
No responsibility is assumed by the Publisher for any injury and/or damage to persons
or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions
or ideas contained in the material herein. Because of the rapid advances made in the medical sciences, independent verification of diagnoses
and drug dosages should be made.
Review of manuscripts
Upon receipt, a manuscript will be peer-reviewed. The
reviewers' relevant comments and the editor's decision will be communicated to the authors.
TITLE
It should
be carefully chosen to provide precise information about the contents and include important keywords. The title should be followed by
the full name(s) of the author(s) and by his (her, their) affiliation(s). Different affiliations should be indicated by suitable superscripts.
To ensure identification of the corresponding author, please indicate full name, full postal address, e-mail address, phone and facsimile
on the cover of the manuscript.
RESEARCH PAPERS
Should contain the following sections: Introduction, Theoretical
Development (if applicable), Materials and Methods, Results, Discussion (or Results and Discussion) and References. For purely theoretical
papers, appropriate sections may be selected.
USE OF DIGITAL OBJECT IDENTIFIER (DOI)
The digital object identifier
(DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned
to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium
for citing a document particularly "Articles in press" because they have not yet received their full bibliographic information.
The correct format for citing DOI is shown as follows: doi:10.1016/j.ejpb.2004.10.006
Notes
The research
and technical notes section of the journal (maximum 2500 words) is open to interesting results worthy of publication without requiring
extensive introduction and discussion. This section should contain the following subheadings: Abstract, Introduction, Materials and Methods,
Results and Discussion (combined). No more than 10 references should be used. Tables, figures and references are to be arranged according
to research papers. Brevity of presentation is essential for this section. Five to 10 keywords should be provided.
Review
articles
The organization and subdivision of review articles can be arranged at the author's discretion. Tables, figures
and references are to be arranged according to research papers. An abstract, table of contents, and keywords are requested.
Correcting
proofs and reprints
Elsevier will send PDF proofs to authors by e-mail for correction. If an author is unable to handle
this process, regular print proofs will be sent. Elsevier will do everything possible to get the article corrected and published as quickly
and accurately as possible. Therefore, it is important to ensure that all corrections are sent back in one communication. Subsequent
corrections will not be possible. Only typesetting errors may be corrected; no changes in, or additions to, the accepted manuscript will
be allowed. Proofs should be returned to Elsevier within 48 hours.
EJPB has no page charges. Fifty offprints of each
paper will be supplied free of charge to the corresponding author. Additional offprints can be ordered at prices shown on the offprint
order form that accompanies the copyright form.
For
inquiries relating to the submission of articles (including electronic submission where available) please visit this journal's homepage.
You can track accepted articles at
http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when
an article's status has changed. Also accessible from here is information on copyright, frequently asked questions and more. Contact
details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company